If you feel that your current medication is no longer producing results , several adjustments are worth discussing with your provider
Dr Sonya Babu-Narayan, associate medical director at the British Heart Foundation and consultant cardiologist, has previously spoken of the exciting potential of this class of drugs, known as GLP-1 agonists
QUE exerts dose-dependent inhibition of drug-metabolizing enzymes and transporters in rats, significantly altering cyclosporine pharmacokinetics (89, 90)
References Zanotti R, Tanasi I, Crosera L, et al
Moreover, oral semaglutide was shown to improve surrogate outcomes versus liraglutide in PIONEER 4, with these improvements projected to lead to long-term benefits in the present study [11]